-
Sacituzumab Govitecan-hziy Plus Pembrolizumab Improves PFS in Patients With Metastatic Triple-Negative Breast Cancer
24 Apr 2025 17:33 GMT
… ; Bristol-Myers Squibb], paclitaxel [Abraxane; Abraxis BioScience, … metastatic triple-negative breast cancer (ASCENT-04). … Navigating triple-negative breast cancer treatment with sacituzumab … navigating-triple-negative-breast-cancer-treatment-with-sacituzumab …
-
ROS-Responsive Biomimetic Nanocomplexes of Liposomes and Macrophage-Derived Exosomes for Combination Breast Cancer Therapy
23 Apr 2025 15:59 GMT
… mainly include anthracyclines, paclitaxel, and certain … therapeutic efficacy against breast cancer.
Abbreviations
MPS, … enhanced triple-negative breast cancer treatment through … dihydroartemisinin effectively treat breast cancer by enhancing reactive …
-
Study Decodes Deescalation: Impact of BRCA Pathogenic Variants on Neoadjuvant Treatment in Triple-Negative Breast Cancer
22 Apr 2025 18:26 GMT
… regimens—nab-paclitaxel combined with … -stage triple-negative breast cancer (TNBC) patients. … paclitaxel combined with carboplatin versus gemcitabine, in early-stage triple-negative breast cancer … Patients With Triple-Negative Breast Cancer. *JAMA Network …
-
Keeping Up With The Growing Number of Treatments for Breast Cancer
22 Apr 2025 18:19 GMT
… of early detection.³,⁵
Breast cancer treatment is highly … nausea, and neutropenia; paclitaxel and docetaxel are associated … patients receiving trastuzumab.
Breast cancer remains a critical … positioned to support breast cancer patients through our …
-
AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data
22 Apr 2025 14:16 GMT
… treatment paradigm in HER2+ metastatic breast cancer,” adding that doctors seem “ … a taxane chemotherapy (docetaxel or paclitaxel), Roche’s monoclonal antibodies … patients with metastatic or unresectable breast cancer with ultralow expression levels …
-
AstraZeneca, Daiichi Sankyo announce Enhertu plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in PFS vs. THP to treat HER2─positive metastatic breast cancer
22 Apr 2025 05:11 GMT
… HER2-positive metastatic breast cancer: Breast cancer is the second … taxane [docetaxel or paclitaxel], trastuzumab and pertuzumab) … new breast cancer settings.
In HR-positive breast cancer, … negative breast cancer, an aggressive form of breast cancer, …
-
Gilead’s Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1-Positive Metastatic Triple-Negative Breast Cancer
21 Apr 2025 21:18 GMT
… 10) metastatic triple-negative breast cancer (mTNBC). Full results from … plus carboplatin, paclitaxel, or nab-paclitaxel.
The trial’ … HR+/HER2- metastatic breast cancer (MBC). Gilead is … United States will develop breast cancer in their lifetime. …
-
Nanoparticle-Based Strategies to Enhance the Efficacy of STING Activators in Cancer Immunotherapy
26 Apr 2025 05:08 GMT
… -deficient triple-negative breast cancer and ERCC1-deficient … melanoma and triple-negative breast cancer.17 Collectively, these … in melanoma and breast cancer models.152 Furthermore, … responsive polymeric nanoparticles for paclitaxel delivery. Colloids Surf …
-
Annexin A: Cell Death, Inflammation, and Translational Medicine
26 Apr 2025 05:08 GMT
… primarily cancer. In breast cancer, Annexin A9 downregulation … by tetramethoxystilbene in human breast cancer cells. Biomolecules Ther … S100A4 and promotes breast cancer progression through modulating STAT3 … and rabbits after paclitaxel treatment with (18 …
-
China’s NMPA Approves Toripalimab in First-Line Melanoma
25 Apr 2025 19:41 GMT
… metastatic NPC; in combination with paclitaxel and cisplatin in first-line … paclitaxel for injection in first-line recurrent or metastatic triple-negative breast cancer …
About
© 1995-2025